Actions - Pharma
Retour à la Hiérarchie des Classes d'Actions
Propensions (en %)Hausse 21%Neutre 38%Baisse 42%
| Rang Tech. | Actions | Cours | Synthèse Technique | Momentums | Accé- léra- tion | Tac- tique | ROBO Analyse | Secteurs | PER (X) | Rendt (%) | Croiss. BPA | Croiss. CFA | Croiss. BKV | Croiss. Ventes | Marge Nette | Rentab. Cap.Inv | Dettes ebitda | Tickers | Capi. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Absolu | Relatif | |||||||||||||||||||
| 79 | Eli Lilly | 882.2 | ++++ | ++ | +++++ | + | * * | Pharma | 37.6 X | 0.6% | +++++ | +++++ | +++++ | +++++ | ++++ | +++++ | ++ | LLY | BIG | |
| 77 | Bayer | 23.40 | ++++ | ++ | ++++ | Neutre | Pharma | 9.9 X | 9.9% | - - - - - | Neutre | - - - - | - - - | - | - - - | - - - - - | BAYN | BIG | ||
| 70 | Orion | 54.80 | ++++ | ++ | ++++ | Neutre | * * | Pharma | 22.2 X | 4.0% | - - - | Neutre | +++ | ++++ | ++++ | ORNBV | MID | |||
| 46 | GSK | 1 478 | +++ | + | +++ | Neutre | * | Pharma | 10.2 X | 4.1% | - - - - | ++ | ++ | - - - | ++++ | ++++ | - | GSK | BIG | |
| 42 | Taux = + 25% | +++ | + | |||||||||||||||||
| 24 | Takeda Pharma | 4 340 | + | Neutre | ++ | Neutre | Pharma | 9.1 X | 4.0% | +++ | Neutre | ++++ | - - - - | - - - | 4 502 | BIG | ||||
| 21 | Taux = + 10% | + | Neutre | |||||||||||||||||
| 8 | Astellas Pharma | 1 428 | Neutre | - | + | + | Pharma | 12.7 X | 3.6% | +++++ | +++ | ++ | ++ | ++++ | 4 503 | MID | ||||
| 8 | Hikma Pharm. | 1 989 | Neutre | Neutre | + | Neutre | Pharma | 12.2 X | 2.8% | ++ | ++++ | ++++ | Neutre | +++ | +++ | Neutre | HIK | MID | ||
| 8 | Virbac | 306.8 | Neutre | Neutre | + | Neutre | Pharma | 20.3 X | 0.5% | ++ | +++ | ++++ | ++ | Neutre | ++ | ++++ | VIRP | Small | ||
| 6 | Tx ESTER j/j rate | Neutre | Neutre | |||||||||||||||||
| 5 | Novartis AG | 93.70 | Neutre | Neutre | + | Neutre | Pharma | 17.3 X | 3.9% | Neutre | ++ | - - - - - | Neutre | ++++ | +++++ | ++ | NOVN | BIG | ||
| 4 | Johnson & John. | 155.7 | Neutre | Neutre | + | Neutre | Pharma | 17.1 X | 3.1% | - - - - | ++++ | + | - - - | ++++ | +++++ | ++++ | JNJ | BIG | ||
| 0 | Taux ZERO | Neutre | Neutre | |||||||||||||||||
| -3 | Roche | 290.2 | Neutre | Neutre | Neutre | Neutre | Pharma | 18.1 X | 3.2% | + | - - - | +++ | - - - | ++++ | +++++ | + | ROG | BIG | ||
| -4 | Vetoquinol | 73.30 | Neutre | Neutre | Neutre | Neutre | Pharma | 14.9 X | 1.2% | Neutre | Neutre | + | Neutre | + | - | +++++ | VETO | Small | ||
| -5 | Recordati | 51.00 | Neutre | - | Neutre | Neutre | Pharma | 18.1 X | 2.8% | +++ | +++ | ++++ | +++++ | - | REC | MID | ||||
| -5 | Amgen | 288.5 | Neutre | Neutre | Neutre | - | Pharma | 24.9 X | 3.0% | - - | ++++ | + | +++++ | ++++ | ++++ | - - - | AMGN | BIG | ||
| -10 | Taux = - 5% | Neutre | Neutre | |||||||||||||||||
| -11 | Sandoz | 35.80 | - | - | Neutre | Neutre | Pharma | 18.1 X | 3.2% | + | - - - | +++ | - - - | ++++ | +++++ | + | SDZ | BIG | ||
| -13 | Sanofi | 96.40 | - | - | Neutre | Neutre | Pharma | 13.8 X | 3.7% | +++++ | ++++ | Neutre | ++ | +++ | Neutre | +++ | SAN | BIG | ||
| -15 | AstraZeneca | 10 781 | - | - | Neutre | Neutre | Pharma | 22.3 X | 2.1% | ++++ | +++++ | ++ | ++ | ++++ | ++ | + | AZN | BIG | ||
| -16 | Taux = - 10% | - | Neutre | |||||||||||||||||
| -25 | Merck | 84.50 | - - | - - | - | + | Pharma | 11.2 X | 3.1% | ++++ | ++++ | +++ | + | +++++ | +++++ | ++ | MRK | BIG | ||
| -29 | Pfizer | 23.70 | - - | - | - | Neutre | Pharma | 16.8 X | 6.2% | - - - - - | - - - | - - - | - - - - - | +++ | - | - - - | PFE | BIG | ||
| -29 | UCB | 159.9 | - - | - - | - - | Neutre | Pharma | 38.1 X | 0.7% | + | +++++ | + | +++++ | +++ | Neutre | ++ | UCB | BIG | ||
| -31 | Taux = - 20% | - - | - | |||||||||||||||||
| -35 | Ipsen | 101.1 | - - | - - | - - | Neutre | Pharma | 15.9 X | 1.0% | - | - - | ++++ | ++++ | ++++ | +++ | ++++ | IPN | MID | ||
| -38 | Taux = - 25% | - - | - | |||||||||||||||||
| -41 | Merck KG | 121.9 | - - - | - - | - - | Neutre | Pharma | 21.4 X | 1.5% | + | + | Neutre | - - | ++ | Neutre | - | MRK | BIG | ||
| -71 | Lundbeck | 31.30 | - - - - | - - - | - - - - | Neutre | Pharma | 14.3 X | 1.6% | +++++ | ++++ | +++ | ++ | +++ | ++ | ++++ | HLUN B | MID | ||
| -80 | Novo Nordisk | 430.0 | - - - - - | - - - | - - - - | Neutre | Pharma | 22.1 X | 1.8% | ++++ | ++++ | +++++ | +++++ | +++++ | +++++ | +++ | NOVO B | BIG | ||